3 Top Marijuana Stocks to Buy Without Hesitation

The recent ruling by the South Dakota Supreme Court that struck down a voter referendum approving legalized marijuana shows the difficult road ahead for cannabis stocks in dealing with…

state-by-state approvals. A cohesive, national policy is required.

That’s why the introduction of a Republican-sponsored bill to legalize pot at the federal level is an important development. It could point the way toward a bipartisan agreement. But whether marijuana remains a patchwork quilt of state sanction or it gets the nod nationally, the following three cannabis companies are ones to buy right now.

What’s not to like about rising revenue and widening margins?

Alex Carchidi (Scotts Miracle-Gro): I’d be willing to buy a few shares of Scotts Miracle-Gro (NYSE:SMG) without hesitation because it’s a highly diversified business that makes the gardening tools and plant nutrients that marijuana growers need to keep making money.

As a result of hot demand from newly opened cannabis facilities, its cannabis cultivation equipment subsidiary, Hawthorne, is driving much of the company’s top-line growth. Though its sales contracted by 2% year over year for Q4, Hawthorne’s full-year revenue for 2021 grew by 39%, which isn’t half bad. Similarly, because of the strong seasonality of Scotts’ consumer gardening segment, fourth-quarter revenue dipped 17%, but companywide sales for the year grew by 19%.

As the marijuana industry in the U.S. continues to grow, it’ll continue to need the gear Hawthorne provides in greater and greater quantities. Plus, if consumers need to buy cannabis year-round, Hawthorne will need to sell growers the right gear every quarter, which could reduce some of the seasonality that I suspect scares some investors away from Scotts’ stock.

Right now, there’s every indication that the company will rise to meet the marijuana boom and reward its shareholders in the process. Scotts is improving its efficiency over time across several metrics while committing to another round of share repurchases worth up to $300 million in 2022. Over the past five years, its annual profit margin has risen by nearly 26%, reaching its current level of 10.41%. And its annual return on invested capital (ROIC) rose by 70.3% in the same period, reaching 18.53%. That means the company is getting better at squeezing more money out of both its operations and its equity from sources such as shareholders.

In short, Scotts has the right set of products in the market at the right time, and it has a history of pulling through for its shareholders over the long term. For me, there’s nothing better.

Thumbs up for this bargain weed stock

Eric Volkman (Green Thumb Industries): Pot companies with a strong retail presence will be the first ones to benefit when federal cannabis law is reformed, or several more states flip the switch on recreational legalization. Granted, neither is likely to happen anytime soon, but Green Thumb Industries (OTC:GTBIF) is a company beautifully poised to leap on the opportunity.

In many ways, Green Thumb is a bellwether retail-facing pot stock, as it’s among the top three U.S. multistate operators (MSOs) in terms of revenue, along with rivals Curaleaf and Trulieve Cannabis. It also bucks the money-losing MSO standard by being consistently in the black of late, with five consecutive quarters of bottom-line profitability.

In fact, Green Thumb did smashingly well in its most recently reported quarter. Its Q3 revenue came in at $235 million, 49% higher year over year and 5% better than the Q2 result. Net profit leaped even further ahead; at $21.6 million it was more than double the year-ago figure, although it represented an 8%  decline from the previous quarter.

Among the major U.S. MSOs, in my opinion Green Thumb has one of the best geographic footprints.

This starts with its own home state, Illinois, in which recreational weed got off to a roaring start when it became law at the beginning of 2020. In October, the state surpassed $1 billion in year-to-date recreational sales. That’s well above the total for the entirety of 2020, which was only $669 million. Green Thumb’s Rise is a go-to dispensary in the state, with nine locations.

Green Thumb’s retail presence covers not only established locales such as Illinois, but…


Continue reading at THE MOTLEY FOOL


You May Also Like

About the Author: admin

Leave a Reply

Your email address will not be published.